- Poster presentation
- Open Access
Stress perfusion CMR reliably risk stratifies patients with prior exercise treadmill testing
© Bertaso et al; licensee BioMed Central Ltd. 2011
- Published: 2 February 2011
- Cardiac Magnetic Resonance
- Ischaemic Heart Disease
- Major Adverse Cardiac Event
- Stress Perfusion
- Death Registry
To determine the clinical utility of stress perfusion cardiac magnetic resonance (CMR) in patients with prior exercise treadmill test (ETT).
ETT is an inexpensive and easily accessible non-invasive test. However it affords only modest sensitivity and specificity for ischaemic heart disease (IHD). Accordingly ETT can often provide results that are either equivocal or which run contrary to clinical suspicion. Therefore, clinicians frequently request an additional non-invasive test to clarify matters. Adenosine stress perfusion CMR has been shown to have a high sensitivity and specificity for the detection of IHD. We sought to evaluate a cohort of patients who had a recent ETT followed by stress perfusion CMR to examine the clinical utility of CMR in risk stratifying these patients.
Retrospective analysis of patients referred for adenosine stress perfusion CMR in whom an ETT had been performed in the previous three months. Perfusion imaging was obtained at stress (adenosine 140 µg/kg/min) and rest on a 1.5T scanner. Late enhancement was assessed with dual pass gadolinium (0.2mmol/kg total dose). Patient records, hospital databases and national death registries were reviewed. Major adverse cardiac events (MACE) comprising death, myocardial infarction, revascularisation or ischaemic hospitalisation were evaluated.
Seventy patients (50% male, age 58.4 years ±11.2; mean ±SD) were identified. Twelve (17%) had a history of previous MI or revascularisation. Seventeen had an objectively positive ETT, of which 7 (41%) had a positive stress CMR. Thirty one had an equivocal ETT, of which 8 (26%) had a positive stress CMR. Twenty two had a negative ETT, of which 3 (14%) had a positive CMR. All positive CMRs had stenoses ≥50% at angiography, except for two patients (11%), both from the equivocal ETT group. A negative CMR, irrespective of ETT status, resulted in a 0% MACE rate at median 23 months (IQR 20-27) follow up. No positive CMRs were seen in negative or equivocal ETTs where ≥ 10 metabolic equivalents (METS) were attained.
Adenosine stress perfusion CMR can reliably risk stratify patients independent of previous ETT result. A negative CMR is associated with an excellent prognosis at a median of 23 months follow up.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.